Every earnings call for HCG — management tone, guidance, KPIs and promise tracking, quarter by quarter.
HCG · 4 transcripts · Healthcare · latest Q3 FY26Revenue ₹633 cr (+13% YoY); Adjusted EBITDA ₹111 cr (+20% YoY); EBITDA Margin 17.5%. Revenue grew 13.4% YoY to INR 633 crore in Q3 FY26.
Read full transcript & analysisAdjusted EBITDA FY25 ₹396 cr (+17% YoY); Adjusted EBITDA Margin FY25 17.8%; PAT FY25 ₹44 cr. Revenue (ex-Milann) grew 20% in Q4 FY25 to INR571.1 crores.
Read full transcript & analysisRevenue ₹2,200 cr; EBITDA ₹396 cr. Revenue of ₹2,200 crores in FY2025, growing at a 15% CAGR (FY20-25).
Read full transcript & analysisRevenue ₹559 cr (+19% YoY); Adjusted EBITDA ₹92 cr (+15% YoY); Adjusted EBITDA Margin 16.5%. Revenue of INR 559 crores, up 19% YoY.
Read full transcript & analysis